Hardest CST Practice Questions — Can You Answer These?

If a patient refuses site marking, the refusal must be documented in the medical record. However, the site must still be identified and verified by the team. Clinical Pearl: The surgeon is ultimately responsible for the marking, which must be visible after the patient is prepped and draped. Strategy Tip: NBSTSA emphasizes that while the surgeon marks the site, the CST must confirm the mark is present and visible during the Time-Out. If the mark is missing, the procedure must not start until the surgeon marks it.

The CST must immediately notify the circulator and surgeon of the discrepancy. The patient cannot be transported to the OR until the conflict is resolved. Clinical Pearl: The consent is the legal document; if it contradicts the schedule, the surgeon must clarify with the patient and potentially obtain a new, correct consent. Strategy Tip: On the CST exam, any discrepancy in identification or consent requires a Stop and Verify approach. Never assume the schedule is correct over the signed consent.

The patient is assigned a temporary unique identifier (e.g., John Doe with a specific trauma number) and a corresponding ID band. This temporary ID is used for all records, blood products, and the surgical consent. Clinical Pearl: In life-threatening emergencies, implied consent is used, but the unique ID band must still be used to prevent errors. Strategy Tip: NBSTSA may test John Doe protocols. The priority is a unique, trackable identifier that matches the blood bank and laboratory records.

The CST must advocate for the Universal Protocol by asking the surgeon to stop draping so that a proper Time-Out can be conducted. Clinical Pearl: The Time-Out requires the suspension of ALL activity. Draping, instrument counting, or suctioning must cease. Strategy Tip: The NBSTSA tests the CST's role as a patient advocate. A passive CST is a wrong answer; the CST must actively participate and ensure the Stop occurs.

The site is verified through a two-stage process: 1) Preoperative marking of the general skin site, and 2) Intraoperative radiographic imaging (X-ray/Fluoroscopy) to confirm the exact vertebral level before the procedure starts. Clinical Pearl: For non-obvious sites like the spine, the CST must ensure the C-arm or X-ray is available and that the surgeon confirms the level on the film. Strategy Tip: NBSTSA emphasizes that skin marking alone is insufficient for spinal levels; imaging is the gold standard for verification.